ARTICLE | Clinical News
Nexavar sorafenib regulatory update
February 3, 2014 8:00 AM UTC
The European Commission granted Orphan Drug designation to sorafenib from Bayer to treat follicular and papillary thyroid cancer. In December, FDA approved an sNDA for Nexavar sorafenib to treat local...